Eli Lilly Records Record $10 Billion In 1999 Despite Lagging Prozac Sales

OPEN MINDS, The Behavioral Health & Social Service Industry Analyst Industry News Eli Lilly and Company has reported worldwide sales for 1999 were more than $10 billion, an increase of 8%. In addition, operating income for the fourth quarter jumped 20%, even as sales of its leading antidepressant drug Prozac fell 13%, according to a January 27 press release. Eli Lilly said fourth quarter profits, excluding one-time items, increased 20% to $671.7 million. Year-end net income and earnings per share increased 30%, to $2.721 billion, and 32%, to $2.46, respectively. Excluding one-time events, net . . .